New medications under FDA review, such as dual and triple agonists, are showing 20-30% weight loss in trials, monthly dosing options, and more flexible oral formulations are all in late-stage development
Intestinal plasticity and metabolism as regulators of organismal energy homeostasis
Does tirzepatide or semaglutide cause more side effects
Following this spike, prescribing was relatively stable from September through November (0.01 percentage points per month), before increasing again from November to December (+0.04 points) and accelerating from December 2025 through February 2026 (+0.12 percentage points per month)
There was no difference in brain weight among the groups at P20 and 13 week (Table 1)
Tirzepatide has a longer half-life of 5 days per injection cycle, and most transition protocols recommend either overlapping low-dose tirzepatide introduction or a brief washout period before starting tirzepatide dosing to minimize gastric side effects and receptor saturation